RhumbLine Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-94,287
| Closed | -$14.3M | – | 3092 |
|
|
2022
Q3 | $14.3M | Buy |
94,287
+14,804
| +19% | +$2.24M | 0.02% | 704 |
|
|
2022
Q2 | $11.6M | Buy |
79,483
+17,015
| +27% | +$2.48M | 0.02% | 830 |
|
|
2022
Q1 | $7.41M | Sell |
62,468
-1,344
| -2% | -$159K | 0.01% | 1096 |
|
|
2021
Q4 | $8.79M | Sell |
63,812
-347
| -0.5% | -$47.8K | 0.01% | 1055 |
|
|
2021
Q3 | $8.91M | Buy |
64,159
+2,421
| +4% | +$336K | 0.01% | 1022 |
|
|
2021
Q2 | $5.99M | Buy |
61,738
+9,861
| +19% | +$957K | 0.01% | 1330 |
|
|
2021
Q1 | $3.55M | Sell |
51,877
-6,890
| -12% | -$471K | ﹤0.01% | 1599 |
|
|
2020
Q4 | $5.04M | Buy |
58,767
+2,189
| +4% | +$188K | 0.01% | 1355 |
|
|
2020
Q3 | $3.68M | Sell |
56,578
-13,364
| -19% | -$869K | 0.01% | 1345 |
|
|
2020
Q2 | $5.11M | Buy |
69,942
+14,207
| +25% | +$1.04M | 0.01% | 1200 |
|
|
2020
Q1 | $1.9M | Buy |
55,735
+4,467
| +9% | +$152K | ﹤0.01% | 1577 |
|
|
2019
Q4 | $2.79M | Buy |
51,268
+3,229
| +7% | +$176K | ﹤0.01% | 1609 |
|
|
2019
Q3 | $2M | Buy |
48,039
+5,022
| +12% | +$209K | ﹤0.01% | 1747 |
|
|
2019
Q2 | $1.88M | Buy |
43,017
+3,377
| +9% | +$148K | ﹤0.01% | 1779 |
|
|
2019
Q1 | $2.04M | Buy |
39,640
+2,895
| +8% | +$149K | ﹤0.01% | 1701 |
|
|
2018
Q4 | $1.36M | Buy |
36,745
+12,587
| +52% | +$466K | ﹤0.01% | 1867 |
|
|
2018
Q3 | $907K | Sell |
24,158
-1,355
| -5% | -$50.9K | ﹤0.01% | 2041 |
|
|
2018
Q2 | $1.01M | Sell |
25,513
-2,420
| -9% | -$95.6K | ﹤0.01% | 2006 |
|
|
2018
Q1 | $720K | Buy |
27,933
+19,160
| +218% | +$494K | ﹤0.01% | 2077 |
|
|
2017
Q4 | $237K | Sell |
8,773
-1,787
| -17% | -$48.3K | ﹤0.01% | 2560 |
|
|
2017
Q3 | $395K | Buy |
10,560
+288
| +3% | +$10.8K | ﹤0.01% | 2436 |
|
|
2017
Q2 | $257K | Buy |
+10,272
| New | +$257K | ﹤0.01% | 2634 |
|